| Factor Information | |
|---|---|
| Data ID | 2725 |
| Factor | Steroid |
| Description | The number of non-steroid leads was higher in the failure subgroup compared with the non-failure group, 27.6% versus 12.4% (p=0.03). |
| Biomarker | NA |
| Classification | E10 (physiological factor - other) |
| Association | |
|---|---|
| Application | risk assessment |
| Objective | We evaluate the incidence of epicardial lead failure and try to identify risk factors in patients with congenital heart disease. |
| p Value | 0.03 |
| Conclusion | The number of non-steroid leads was higher in the failure subgroup compared with the non-failure group, 27.6% versus 12.4% (p=0.03). |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 616 |
| CHD Type | isolated CHD |
| CHD Subtype | LVOTO/ASD/VSD/AVSD/TGA/TOF/other |
| Reference | |
|---|---|
| PMID | 21567217 |
| Year | 2011 |
| Title | Failure of epicardial pacing leads in congenital heart disease: not uncommon and difficult to predict |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | Patients' medical records and lead data were reviewed. | |
| Region | Leuven, Belgium | |
| Method | Patients' medical records and lead data were reviewed. | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | (epicardial lead) Failure(Treatment) | (epicardial lead) No Failure(Control) |
| Number | 29 | 169 |
| Age | Age at implantation: 3.7±3.6 years | Age at implantation: 8.2±10.0 years |
| Gender (Male: Female) | 17:12 | 97:72 |
| Marker Level | 21 (12.4%) | 148 (87.6%) |
